In conclusion, the simultaneous treatment of calcitriol or its analogs with TKI’s in TNBC and HER2-positive BC cells is significantly better than monotherapy as antineoplastic treatment, resulting in a greater antiproliferative and pro-apoptotic effect. Here, ERBB2 is linked to breast cancer.